Therapeutic Drug Monitoring of Posaconazole in Allogeneic Hematopoietic Stem Cell Transplantation Patients Who Develop Gastrointestinal Graft-versus-Host Disease

Posaconazole (PCZ) is the latest triazole antifungal agent that has been approved for prophylaxis of invasive aspergillosis in high-risk immunocompromised patients, such as allogeneic hematopoietic stem cell transplantation patients, who develop graft-versus-host disease (GVHD). PCZ has high interin...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Tonini, J., Thiébaut, A., Jourdil, J. F., Berruyer, A. S., Bulabois, C. E., Cahn, J. Y., Stanke-Labesque, F.
Formato: Artigo
Lenguaje:Inglês
Publicado: American Society for Microbiology 2012
Materias:
Clinical Therapeutics
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC3457412/
https://ncbi.nlm.nih.gov/pubmed/22850515
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.00815-12
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares